Loading...
  • cancers
  • In 1959, thiotepa was registered with the Food and Drug Administration (FDA) as a drug therapy for several solid cancers. (wikipedia.org)
  • gastric
  • On 21 April 2014, the US Food and Drug Administration (FDA) approved ramucirumab, as a single agent or with paclitaxel, for treatment of advanced gastric or gastro-esophageal junction adenocarcinoma if the disease has progressed despite fluoropyrimidine- or platinum-containing chemotherapy. (wikipedia.org)
  • surgically
  • We retrospectively investigated the histopathological and radiographic data of 348 surgically resected cT1N0M0 lung adenocarcinoma patients with systematic lymph node dissection from January 2005 to December 2012. (deepdyve.com)
  • Capecitabine
  • As of 2016, momelotinib is being investigated for primary myelofibrosis or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (post-PV/ET MF), as well as a treatment for relapsed or refractory metastatic pancreatic ductal adenocarcinoma (in combination with capecitabine and oxaliplatin). (wikipedia.org)
  • liquids
  • Dysphagia (difficulty swallowing, solids worse than liquids) and painful swallowing are common initial symptoms. (wikipedia.org)
  • The first and the most common symptom is usually difficulty in swallowing, which is often experienced first with solid foods and later with softer foods and liquids. (wikipedia.org)
  • lymph node
  • Among 110 patients with a solid component proportion of no more than 21.3%, mediastinal lymph node involvement was not observed. (deepdyve.com)
  • The solid component evaluated on computed tomography can predict the invasiveness and lymph node metastasis in lung adenocarcinoma as well as patho. (esmo.org)
  • clinical
  • Additionally, an oral AXL inhibitor (TP-0903) is expected to enter Phase 1 clinical trial in November 2016 (in advanced solid tumours: NCT02729298). (wikipedia.org)